Study Complete
Official Title
*Please Note* The Study you are attempting to view was acquired from Takeda by AstraZeneca and was disclosed initially by Takeda per their Transparency Policies. More information regarding this study may be available by contacting [email protected].
Medical condition
Chronic Obstructive Pulmonary Disease
Phase
Phase 2/3
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
516
Study type
Interventional
Age
40 Years - 75 Years
Date
Study Start Date: 01 Oct 1999
Primary Completion Date: -
Study Completion Date: 01 Feb 2001
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jun 2016 by Takeda
Sponsors
Takeda
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
